Ironwood Pharmaceuticals IRWD Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's net income?
- Ironwood Pharmaceuticals (IRWD) reported net income of $40.77M in Q1 2026.
- How has Ironwood Pharmaceuticals's net income changed year-over-year?
- Ironwood Pharmaceuticals's net income increased by 209.1% year-over-year, from -$37.39M to $40.77M.
- What is the long-term trend for Ironwood Pharmaceuticals's net income?
- Over 4 years (2021 to 2025), Ironwood Pharmaceuticals's net income has grown at a -53.8% compound annual growth rate (CAGR), from $528.45M to $24.02M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.